SUPPLEMENTARY MATERIALS AND METHODS

Construction of the operator variants
The following 55-bp operator variants (with the names indicated on the left) were used in the affinity assays: 
NS
The numbers above the ends of the wild-type (WT) operator correspond to the coordinates on the pMV158 sequence. The 13-bp pseudo-symmetric element (SE) is displayed in italics on the sequence of the WT operator, with its twofold axis denoted by a small line. Sequence substitutions in the various mutant operators are shown in boldface. The same mutant sequence (5'-GACTTGA-3' from the centre of the SE) was employed to substitute the RSE and the LSE in the corresponding mutant operators lacking these binding sites. The RA and LA were replaced with the sequence at either side of the EcoRI site of the pBluescript SK+ plasmid vector (STRATAGENE), where the SE of the CopG operator had been cloned (unpublished results). In the non-specific (NS) oligonucleotide, the sequence of all four binding sites was substituted accordingly.
The top and bottom strands of each of the above oligonucleotides were synthesized separately and purified by electrophoresis in 12% PAA sequencing gels. The top strand was 5'-end labelled with [γ-32 P]ATP and T4 polynucleotide kinase and subsequently annealed to a 3-fold molar excess of the corresponding unlabelled bottom strand.
Relative affinity assays
The relative affinity of binding of CopG to the different operator mutants was determined by competitive electrophoretic mobility shift assays (EMSA), in a way similar to that previously described (1) . Basically, CopG was incubated in 6 μl BB buffer with a mixture of the 5'-end labelled 239-bp DNA fragment containing the wild-type promoter/operator sequence and one of the 55-bp operator variants (also 5'-end labelled). Free and complexed DNAs from both fragments were separated by electrophoresis on 8% native PAA gels. Labelled DNA bands were detected and quantified with the storage phosphor technology, with the aid of a FLA-3000 (FUJIFILM) imaging system and the Quantity One software (Bio-Rad). The affinity of CopG for DNA D 1 relative to DNA D 2 [K rel (D 1 /D 2 )] was determined as follows: To normalize the data for potential effects due to the different size (239 bp vs. 55 bp) and origin (PCR amplification vs. chemical synthesis) of the DNAs used in these assays, the affinities of CopG for the 55-bp operator mutants relative to the 239-bp wild-type DNA fragment were divided by the ratio between the protein affinities for the 55-bp WT and 239-bp wild-type DNAs. . . 
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